Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Leta Marie Forbes"'
Autor:
Janet Papadakos, Sarah McBain, Robin McLeod, Lesley Moody, Colleen Fox, Eleni Giannopoulos, Diana Samoil, Leta Marie Forbes, Priyanka Jain, Nicole Mittman
Publikováno v:
Patient Education and Counseling. 104:1398-1405
The development of patient education (PE) materials is costly and resource-intensive, and no mechanisms exist for sharing materials across cancer centers/hospitals to limit duplicated effort. The aim of this study was to explore the incidence and cos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5485f85e1f8d62cfd9ad720fe38bd6e3
https://doi.org/10.1016/j.pec.2020.11.017
https://doi.org/10.1016/j.pec.2020.11.017
Autor:
Eleni Giannopoulos, Diana Samoil, Robin McLeod, Janet Papadakos, Jonathan Wang, Leta Marie Forbes, C Fox, Priyanka Jain, V Zwicker, Lesley Moody, Sarah McBain
Publikováno v:
Supportive Care in Cancer. 29:3513-3519
Most patients diagnosed with cancer are administered systemic therapy and these patients are counselled and given printed education (PE) materials. High rates of low health literacy highlight the need to evaluate the quality of these PE materials. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98a01c06496214782bbeef8e52cd4b66
https://doi.org/10.1007/s00520-020-05859-2
https://doi.org/10.1007/s00520-020-05859-2
Publikováno v:
Journal of Clinical Oncology. 40:234-234
234 Background: Optimal prevention and safe management of febrile neutropenia (FN) in the outpatient setting, when clinically appropriate, can help to keep vulnerable patients from experiencing severe complications requiring hospitalization. Variatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1070ad98b3e7775d13b80cd532f78ff6
https://doi.org/10.1200/jco.2022.40.28_suppl.234
https://doi.org/10.1200/jco.2022.40.28_suppl.234
Autor:
Leta Marie Forbes, Kelvin Kar-Wing Chan, Scott Gavura, Rebecca E Mercer, Lyndee Yeung, Rohini Naipaul
Publikováno v:
Current Oncology
Volume 28
Issue 2
Pages 103-1066
Current Oncology, Vol 28, Iss 103, Pp 1056-1066 (2021)
Volume 28
Issue 2
Pages 103-1066
Current Oncology, Vol 28, Iss 103, Pp 1056-1066 (2021)
The COVID-19 pandemic has a significant impact on cancer patients and the delivery of cancer care. To allow clinicians to adapt treatment plans for patients, Ontario Health (Cancer Care Ontario) issued a series of interim funding measures for the pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d4b233a5e0f4a804e17a276bde5fa18
Autor:
Aliya Pardhan, Leta Marie Forbes, Kathy Vu, Vishal Kukreti, Scott Gavura, Daniela Gallo-Hershberg
Publikováno v:
JCO oncology practice. 17(4)
PURPOSE: Take-home cancer drugs (THCDs) have become a standard treatment of many cancers. Robust guidelines have been developed for intravenous chemotherapy drugs, but few exist for THCDs with a focus on decentralized models. Hence, Ontario Health (C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67654a209965c78f1abf2560ee11cbc7
https://pubmed.ncbi.nlm.nih.gov/33079644
https://pubmed.ncbi.nlm.nih.gov/33079644
Autor:
Roy Lee, David Warr, Geoffrey Liu, Monika K. Krzyzanowska, Jennifer J. Knox, Robert C. Grant, Pamela Ng, Coleman Rotstein, Leta Marie Forbes, Kathy Vu
Publikováno v:
Supportive Care in Cancer
Purpose People with cancer face an elevated risk of infection and severe sequelae from COVID-19. Dexamethasone is commonly used for antiemetic prophylaxis with systemic therapy for cancer. However, dexamethasone is associated with increased risk of v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42df601dfb26767d71eaabbf272f43c2
https://pubmed.ncbi.nlm.nih.gov/32601854
https://pubmed.ncbi.nlm.nih.gov/32601854
Autor:
James Joseph Biagi, Jessica Arias, Jaclyn Beca, Scott Gavura, Xiaochen Tai, Kelvin K. W. Chan, Michael J. Raphael, William Raskin, Steven Habbous, Craig C. Earle, Leta Marie Forbes, Wei F. Dai
Publikováno v:
JAMA Network Open
Key Points Question Are drug-funding reimbursement decisions associated with uptake of new therapies and survival outcomes for patients with advanced pancreatic cancer? Findings In this population-based cohort study of 5465 patients with advanced pan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8934df8b14528a81108a1096725387c
https://doi.org/10.1001/jamanetworkopen.2021.33388
https://doi.org/10.1001/jamanetworkopen.2021.33388
Autor:
Sivanuja Paras, Rosemary Ku, Leta Marie Forbes, Aliya Pardhan, Vishal Kukreti, Kathy Vu, Daniela Gallo-Hershberg
Publikováno v:
Journal of Clinical Oncology. 38:20-20
20 Background: In 2019, Ontario Health (Cancer Care Ontario) published 54 standards to ensure high quality and safe delivery of systemic treatment (ST) in Ontario, along with 16 recommendations for take-home cancer drugs (THCD). The standards/recomme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b16954a5e2de7da646301bb486046749
https://doi.org/10.1200/jco.2020.38.29_suppl.20
https://doi.org/10.1200/jco.2020.38.29_suppl.20
Publikováno v:
Journal of Clinical Oncology. 38:184-184
184 Background: Oral systemic therapy (ST) presents unique care delivery challenges. Gaps in patient education and monitoring for patients on oral ST delivery are well documented and can result in decreased adherence or increased toxicity. Within Ont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40d098f03bda817c8219ed5506985f93
https://doi.org/10.1200/jco.2020.38.29_suppl.184
https://doi.org/10.1200/jco.2020.38.29_suppl.184
Autor:
Andrea Crespo, Anna Granic, Lorraine Martelli, Leta Marie Forbes, Charmaine Mothersill, Sarah McBain, Daniela Gallo-Hershberg, Carlo DeAngelis, Jason Yu, Vishal Kukreti, Ferid Rashid, Lily Spasic, Katherine Enright, Leslie Young
Publikováno v:
Journal of Clinical Oncology. 37:255-255
255 Background: Cancer medication-related infusion reactions (CMIRs) can lead to treatment delays, switching to less optimal therapy, or discontinuation. Variation in the prevention, management and reporting of CMIRs was identified as a quality and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fae9ddbb24dae25b5ebad35335e28794
https://doi.org/10.1200/jco.2019.37.27_suppl.255
https://doi.org/10.1200/jco.2019.37.27_suppl.255